FdaApplication
ANDA 211277
Identifiers
- fda_app_no: ANDA211277
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2020-10-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM NITROPRUSSIDE | SODIUM NITROPRUSSIDE | 25MG/ML | INJECTABLE;INJECTION |
1 product